Magellan Health Inc 's Revenue in the fiscal year 2020 $ 4,577.53 millions
Magellan Health Inc 's Revenue in the fiscal year 2019 $ 7,159.42 millions
Magellan Health Inc 's Revenue in the fiscal year 2018 $ 7,314.15 millions
Magellan Health Inc 's Revenue in the fiscal year 2017 $ 5,838.58 millions
Magellan Health Inc 's Revenue in the fiscal year 2016 $ 4,836.88 millions
MGLN Revenue third quarter 2021 Y/Y Growth Comment
Magellan Health inc achieved in the third quarter 2021, above Company average Revenue improvement of 7.18% year on year, to $ 1,254.12 millions.
Looking into third quarter 2021 results within Healthcare Facilities industry 28 other companies have achieved higher Revenue growth. While Magellan Health Inc ' s Revenue increase of 7.18% ranks overall at the positon no. 2935 in the third quarter 2021.
Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021
Magellan Health Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
126.43 %
3.62 %
-56.16 %
(Mar 31 2021)
MGLN's III. Quarter Q/Q Revenue Comment
Magellan Health inc achieved in the III. Quarter 2021 below company average Revenue growth of 2.73% quarter on quarter, to $ 1,254.12 millions.
Within Healthcare Facilities industry 25 other companies have achieved higher Revenue quarter on quarter growth. While Magellan Health Inc 's Revenue growth quarter on quarter, overall rank is 2080.
Magellan Health inc achieved in the III. Quarter 2021 below company average Revenue growth of 2.73% quarter on quarter, to $ 1,254.12 millions.
Within Healthcare Facilities industry 25 other companies have achieved higher Revenue quarter on quarter growth. While Magellan Health Inc 's Revenue growth quarter on quarter, overall rank is 2080.
Magellan Health Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Sep 30 2021)
12 Months Ending (Jun 30 2021)
12 Months Ending (Mar 31 2021)
12 Months Ending (Dec 31 2020)
12 Months Ending (Sep 30 2020)
Cumulative Revenue 12 Months Ending
$ 4,149.57
$ 4,065.57
$ 3,944.87
$ 4,577.53
$ 5,867.16
Y / Y Revenue Growth (TTM)
-29.27 %
-37.7 %
-45.32 %
-36.06 %
-18.53 %
Year on Year Revenue Growth Overall
Ranking
# 3199
# 3432
# 691
# 3142
# 675
Seqeuential Revenue Change (TTM)
2.07 %
3.06 %
-13.82 %
-21.98 %
-10.1 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 3079
# 1514
# 3532
# 1975
# 3348
Cumulative Revenue growth Comment
Magellan Health Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2021. If the fiscal year would end in Sep 30 2021, Magellan Health Inc 's annual Revenue decrease would be -29.27% year on year to $4,150 millions.
In the Healthcare sector 427 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3199, from total ranking in previous quarter at 3432.
Magellan Health Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2021. If the fiscal year would end in Sep 30 2021, Magellan Health Inc 's annual Revenue drop would be -29.27% year on year to $4,150 millions.
In the Healthcare sector 427 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3199, from total ranking in previous quarter at 3432.
About Magellan Health Inc Revenue Growth Rates (MGLN), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.